Martin Pichler

39PUBLICATIONS
110CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityCancer diagnosisChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Nov 27, 2024
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer.

Paola Parrella, Raffaela Barbano, Katharina Jonas

|Jan 22, 2024
MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B.

Katharina Jonas, Felix Prinz, Manuela Ferracin

|Nov 15, 2023
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.

Gazanfer Belge, Cansu Dumlupinar, Tim Nestler

|Jul 14, 2023
Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types.

Irina Robinson, Maximilian Johannes Hochmair, Manuela Schmidinger

|Jul 01, 2023
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.

Matthäus Majewski, Pia Paffenholz, Christian Ruf

|May 27, 2023
Isochromosome 12p Formation Regulates Vitamin D Metabolism in Testicular Cancer.

Peter Törzsök, Jasper Van Goubergen, Martin Pichler

Pageof 7

Frequent Collaborators

10 joint publications

Dominik Andreas Barth

7 joint publications

Christiane Klec

6 joint publications

Katharina Jonas

4 joint publications

Renate Pichler